Boston Scientific Acquires SVG Embolic Protection At Reduced Cost

Rubicon Medical will forego a higher payment for its embolic filter technology than originally expected from Boston Scientific, opting instead for immediate cash flow to support commercialization

More from Archive

More from Medtech Insight